| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |